Sign in
Not yet taking people in United StatesPhase 2

Duloxetine and walking exercise for veterans with knee osteoarthritis and low mood

Tests duloxetine with an exercise program in veterans with knee osteoarthritis and depression.

Key facts

Who runs it
VA Office of Research and Development
Where
Baltimore, United StatesSee the site
Trial code
Registry title
Duloxetine and aeRobic Exercise to Improve Function in VEterans With Knee Osteoarthritis (DRIVE)
Status
Not yet recruiting
Phase
Phase 2
People taking part
102 people, planned
Starts
1 Mar 2027
Expected to end
1 Sept 2032
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Exercise
  • Duloxetine
  • Placebo
  • PT referral
Record updated
16 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for Veterans aged 40 or older with painful knee osteoarthritis and depressive symptoms. It tests duloxetine and an aerobic walking program.

Age
40 years and older
Sex
All sexes
Disease stage
Knee osteoarthritis with symptoms, based on American College of Rheumatology (ACR) criteria. Mild to severe depressive symptoms on the PHQ-9 questionnaire.
Earlier treatment
People currently using antidepressants, opioids, benzodiazepines or antipsychotics cannot join. People doing structured aerobic or strength exercise 3 or more times per week cannot join.

Main reasons for not taking part

  • Knee surgery planned within the next 6 months
  • Memory or thinking problems with an MMSE score below 20
  • Bipolar disorder, psychosis, recent substance use disorder, or suicidal thoughts
  • Health problems that make exercise unsafe, such as a recent heart attack or blood pressure above 190/110
  • Pregnant or breastfeeding, or cancer now treated with chemotherapy or radiation

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Veterans aged ≥40 years
  • English-speaking
  • symptomatic KOA based on American College of Rheumatology (ACR) criteria
  • Patient Health Questionnaire-9 (PHQ-9) scores indicating mild to severe depressive symptoms
  • no planned knee surgery within the next 6 months
  • ability to participate in supervised aerobic exercise

Who cannot take part

  • active cancer that is currently undergoing treatment (receiving chemotherapy and/or radiation therapy
  • cognitive impairment defined as a Mini-Mental State Examination (MMSE) score <20
  • diagnosis of bipolar disorder, psychosis, recent substance use disorder, or suicidal ideation per the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)
  • medical conditions contraindicating exercise (e.g., recent myocardial infarction, unstable angina, peripheral arterial disease with ulcers, -uncontrolled hypertension >190/110, or New York Heart Association class ≥3 cardiac or pulmonary disease)
  • other conditions deemed by study team to endanger the health of the participant
  • current use of antidepressants, opioids, benzodiazepines, or antipsychotics
  • engaging in structured aerobic or resistance exercise ≥3 times per week
  • pregnant or lactating individuals

Where in United States

  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MDBaltimore, United StatesContact: Alice S Ryan, PhDNot yet recruiting

About the trial

What the trial wants to find out

Knee osteoarthritis (KOA) is one of the most common causes of chronic pain, mobility problems, and disability among United States Veterans. Many Veterans with KOA also experience depressive symptoms, which can worsen pain, reduce motivation to exercise, and make recovery more difficult. This study will test whether a structured hybrid aerobic exercise program that combines supervised and home-based walking with the medication duloxetine can improve physical function, reduce pain, lessen depressive symptoms, and improve overall health-related outcomes in Veterans with KOA. The goal of this research is to develop a practical and scalable treatment strategy that could improve rehabilitation and quality of life for Veterans with chronic knee pain and depressive symptoms and potentially be adapted for other chronic musculoskeletal conditions treated within the VA healthcare system.

The 3 groups in the trial

  • Exercise+DuloxetineExisting treatment, for comparison

    hybrid supervised aerobic exercise plus duloxetine

    Treatment: Exercise and Duloxetine

  • Duloxetine+PT referralExisting treatment, for comparison

    duloxetine plus physical therapy (PT) referral

    Treatment: Duloxetine and PT referral

  • Exercise+PlaceboExisting treatment, for comparison

    hybrid supervised aerobic exercise plus placebo

    Treatment: Exercise and Placebo

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Duloxetine Plus Exercise to Improve Physical Function in Veterans With Knee Osteoarthritis, Pain, and Psychological Comorbidity
Plain-language title
Duloxetine and walking exercise for veterans with knee osteoarthritis and low moodGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
16 June 2026
Duloxetine and aeRobic Exercise to Improve Function in VEterans With Knee Osteoarthritis (DRIVE) (NCT07649291) – Frontlight Research